[1]
2024. Real-world safety of spesolimab in generalized pustular psoriasis: Evidence from an expanded access program in Argentina. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s487. DOI:https://doi.org/10.25251/skin.8.supp.487.